Abselion
Amperia by Abselion enables simple, reliable biomolecule quantification across biologics workflows.
$8.86M Series A ·
Led by M Ventures · Source: startupintros.com
Funding history ↓Signals
About Abselion
Quantify antibodies, AAV capsids and His-tagged proteins.
Abselion | 580 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $8.86M | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
RW
Ruizhi Wang Founder & CEOsource: abselion.com- CVChristoph v. Bieberstein Founder
Investors
BBioProcess360 Partners
BBusiness Growth Fund
MM Ventureslead investor
NNew Ground Ventures
PParkwalk Advisors
RR42 Group
SSwiss Health Angels
UUniversity of Cambridge Enterprise
UUNTITLED
Companies like Abselion
OORF Biologics$1.73M Seed · Jul 2026
AAkamis Bio$60M Series A · Dec 2024
NNormunity$75M Series B+ · Jan 2025
AAnaveon$120M Series B+ · Dec 2021
MMerida Biosciences$120M Series A · May 2025
CChai DiscoverySeries B+ · Jul 2026
Other companies backed by M Ventures
TT-Therapeutics$133M Series B+ · Nov 2026
NNouscom$135.04M Series B+ · Oct 2026
MMueon$65M Series A · Oct 2026
TTRIMTECH Therapeutics$14M Seed · Jun 2026
WWiliot$75M Series B+ · Apr 2026
FFuture Fertility$4.1M Series A · Apr 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/abselion (get a free API key).